Deutsche Bank AG set a CHF 255 price target on Roche Holding Ltd. (VTX:ROG) in a research note issued to investors on Monday. The firm currently has a neutral rating on the healthcare company’s stock.

A number of other research analysts have also commented on ROG. Barclays PLC set a CHF 320 price objective on shares of Roche Holding and gave the company a buy rating in a research report on Saturday, May 20th. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on shares of Roche Holding and gave the company a buy rating in a research report on Saturday, May 20th. J P Morgan Chase & Co reaffirmed a buy rating on shares of Roche Holding in a research report on Saturday, May 20th. Jefferies Group LLC set a CHF 305 price objective on shares of Roche Holding and gave the company a buy rating in a research report on Saturday, May 20th. Finally, Morgan Stanley set a CHF 290 price objective on shares of Roche Holding and gave the company a buy rating in a research report on Saturday, May 20th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the stock. Roche Holding presently has an average rating of Hold and an average price target of CHF 268.20.

Roche Holding (VTX:ROG) opened at 242.40 on Monday. The firm has a market capitalization of CHK 206.83 billion and a P/E ratio of 21.52. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00. The firm has a 50-day moving average price of CHK 243.48 and a 200-day moving average price of CHK 252.56.

COPYRIGHT VIOLATION NOTICE: This report was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/12/roche-holding-ltd-rog-given-a-chf-255-price-target-at-deutsche-bank-ag.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.